Therefore, it is necessary to reevaluate the premise that the genomic instability associated with HORMAD1 expression in breast cancer (Watkins) and lung adenocarcinoma (this report) is necessarily caused by HR defects. This evidence concerns the gene HORMAD1 and breast cancer.